EX-23 3 itos-ex23_1.htm EX-23.1 EX-23

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in this Registration Statement on Form S-8 of our report dated March 15, 2023 relating to the financial statements of iTeos Therapeutics, Inc. appearing in the Annual Report on Form 10-K of iTeos Therapeutics, Inc. for the year ended December 31, 2022.

 

/s/ Deloitte Bedrijfsrevisoren/Réviseurs d’Entreprises BV/SRL

 

Zaventem, Belgium

 

March 15, 2023